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in June 1956 and during the following three or four months
the child was extremely ill, with a swinging temperature.
The outstanding findings were enlargement and other changes
in the liver, a high degree of eosinophilia, and maxirnally
positive tests for disordered liver function. The eosinophil
count ranged from 6,630 to 32,526 per c.mm. (25 - 78 % of
the total white cells) and the serum gamma globulin reached
5 g. per cent. Liver biopsy showed large numbers of char-
acteristic ova in the portal tract, surrounded by dense cellular
infiltration, which in some areas had been replaced by
fibrosis, with marked distortion of the liver pattern and
degeneration of liver cells. The general appearance sug-
gested that the ova were those of a species of Trichuris,
but on further study they were recognized as of Capillaria
hepatica. Capillaria belongs to the same family as Trichuris
(whipworm), which it closely resembles.
This nematode occurs in many animals, and in South
Africa it has been found in rats, mice, rabbits, hares, ger-
billes and meerkats. At the Institute for Medical Research,
Johannesburg, nineteen out of a random group of forty
rats received for examination were found to be infested
with Capillaria. Where the human patient was living, rats
and mice as well as other animals moved freely; and one
field rodent (mastomys) trapped at her home in ovember
1956 showed extensive infestation with Capillaria.
The ova of Capillaria hepatica are not discharged in the
faeces, and only escape from the liver of the host on its
death, when, in rats, they are released through cannibalism
on the part of these rodents. Whether the rat which eats
the liver develops the disease, or whether the ova must
first pass through this animal to be ingested by another,
appears to be uncertain. In any case, the embryonated
eggs pass to the caecum and thence to the liver, where the
worms mature, lay their eggs, and then die and disintegrate.
It is interesting to note that geophagy has been recorded
in the few known human cases, and that the child infected
at Vanderbijlpark is stated to have been 'a prodigious earth-
eater'.
In the treatment of their case our authors were' faced
with the fact that all the four previous cases reported had
ended fatally. They therefore rejected the drugs that had
been given in those cases and, influenced by certain clinical
and histological resemblances to bilharziasis, they selected
an antimony preparation, sodium antimomyl gluconate
('triostam'), which had been reported as effective against
the haematobium and mansoni bilharzia and against try-
panosomes. Large intravenous doses over seven days ap-
peared to clear up the condition and, in a follow-up article2
which appears in the present issue, Cochrane and Skinstad
report that the child is in excellent health and shows no
clinical signs of the severe illness she passed through three
years ago. On exploratory laparotomy the liver is of normal
size and appearance, and on biopsy the only significant
pathological change is some 'not very marked' periportal
fibrosis. The liver function tests are in strong contrast
with those of 1956, the eosinophils now being four per cent
and the gamma globulin 0'9 g. per cent. This is the first
recovery amongst the five human cases reported.
It will be noted that this study, which is an important
contribution to our knowledge of this rare diseas~ in man,
in the fields both of diagnosis and treatment, is based on
cooperation between laboratory workers of the South
African Institute for Medical Research and the clinicians..
1. Cochrane, l. G., Sagorin, L. and Wilcocks, M. G. (1957): S. AfT. Med. l.,
31,751.
2. Cochrane, l. G. and Skinslad, E. E. (1960): Ibid., 34, 21.
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The complex of the shock reaction has been likenedl to a
fugue, which consists of 3 parts, viz. the exposition, the
response and the counterpoint; the exposition being the
noxious stimulus or injury, the response the reaction of the
cardiovascular system and the organism as a whole, and the
counterpoint the means we adopt in treatment. It is in
relation to the counterpoint, or treatment, that I shall confine
my remarks.
The thesis of this paper is that, in association with adequate
blood replacement, ganglion-blocking agents have a funda-
mental and vital part to play in the treatment of haemorrhage,
especially in the more severe types. This therapy is based on
the premise that vasoconstriction is often associated with de-
leterious and undesirable effects, and if prolonged and
unrelieved constitutes a lethal factor in the development of
'irreversibility'. An analysis of vasoconstriction and its
effects is therefore necessary.
• Paper presented at a meeting of the Transvaal Sub-group of
South African Society of Anaesthetists (M.A.S.A.), 27 May 1959.
Vasoconstrictor Response
Intense peripheral vasoconstriction is the common de-
nominator in virtually all forms of shock, irrespective of
the cause, and constitutes a fundamental bodily response.
It is primarily protective in nature, being designed to restrict
fluid and blood loss and maintain the blood supply to the
brain and myocardium. It also incidentally constitutes an
effective barrier to the rapid restoration of the blood volume.
A great deal of experimental and clinical work has been done
in relation to this subject and can be best considered in two
main groups, viz. (1) factors related to vasoconstriction
and (2) factors accompanying vasodilatation. It will be shown
that the former are associated with undesirable sequelae
and the latter with beneficial effects.
There is an accumulation of evidence which suggests
that irreversible shock may be due to excessive prolonga-
tion of the vasoconstrictor reaction, which after a time
becQmes self-perpetuating.2- 5 Irreversible shock has been
produced by prolonged intravenous injection of noradrena-
line in animals which had not suffered fluid or blood loss.6.8
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Therefore the irreversible phase of haemorrhagic shock is
not due to a low blood pressure per se but rather to the
secondary response to vasoconstriction.9•n
That vasoconstriction may be so intense that it actually
hinders peripheral blood flow, is demonstrated by Wang
et al. 12 in some excellent experimental work employing
cYanide which, because of its action via the chemoreceprors,
measures central flow, and fluorescin, which measures
peripheral flow in that it must leave the peripheral system
in order to become visible. These findings have been con-
firmed by other workers.6 0 S
ZweifachI3 in his classic analysis of the microcirculatory
derangements as a basis for the lethal manifestations of
experimental shock has elucidated this problem further.
He has shown that under conditions of moderate hypo-
tension the operation of homeostatic mechanisms is still
adequate to distribute the blood commensurately with
the air requirements of tissue metabolism. But when the
hyPotension is protracted and severe these mechanisms
become ineffective, because arterial and venous constriction
has now progressed to such an extent that changes distal
to the constricted vessels cannot ensure an effective dis-
tribution of blood to the tissues through the capillary vessels.
Two organs which are especially vulnerable' to deficient
circulation during haemorrhagic hypotension are the liver and
intestine. Zweifach shows quite conclusively how this de-
ficiency of tissue flow involves these organs in the decom-
pensatory trend leading to irreversibility.
Thus it is seen that the vasoconstrictor response, initially
protective, if prolonged and severe can become a parent
mechanism in the production of irreversibility. Similarly,
pain perception is a highly important defence against injury,
but no one would suggest that its prolongation was in any
way necessary for the survival of the patient. In fact if
unrelieved it may cause profound shock and exhaustion.
This is an important and basic concept.
Even before vasoconstriction had been observed directly
under the microscope, numerous investigators concluded
that if the body were freed from the influence of the central
nervous system 'marked shock' would fail to produce death
in a significant percentage of cases.' The influence of the
central nervous system has been counteracted by spinal
anaesthesia, subarachnoid injection of procaine, transection
of the spinal cord, and bilateral thoraco-Iumbar sympa-
thectomy.S,U.I8
It has Been demonstrated17•21 that the protection of ex-
perimental animals against. the noxious stimuli of vaso-
constriction by the pre-shocking administration of blocking
agents such as dibenamine, TEA and chlorpromazine results
in a significantly higher survival rate in these animals;
thus showing that vasoconstriction is not necessarily an
effective long-term physiological response to haemorrhage.
Clinically, ganglion-blocking agents were primarily de-
signed to limit bleeding during operation. But it soon
became apparent that these agents afforded some protection
against the development of shock during elective surgery,
and attention immediately became focussed on the possibility
that vasomotor activity was the essential cause of peri-
pberal circulatory failure. 10hnstone1 holds that halothane
has provided strong, if not conclusive, evidence in favour
of the concept that vasoconstriction is an undesirable con-
sequence of trauma or haemorrhage.
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Yasopressor Therapy
De pite the foregoing it has been recommended,22 and
is still generally accepted, that all po ible attempt hould
be made to maintain a nor01olt::nsive head of pr ure with
vasopressor drugs. This recommendation i de erving of a
critical analy is. In spite of the fact that the adrnini tration
of a vasopressor agent i no guarantee that an adequate
blood flow will be maintained in the ti ues a multitude
of clinical reports on the use of noradrenaline (norepine-
phrine in American literature) have appeared. Very few
experimental reports, however, can be found on this subject,
and those that are available reject this as a rational form
of therapy, viz.:
(a) Rerrungton et al. 17 showed that noradrenaline de-
creased the survival rate in dogs subjected to haemorrhage.
(b) Foster et al. 23 working on renal blood flow in haemor-
rhagic shock, found that in spite of a normal pressure
being maintained by noradrenaline 8 out of 10 dogs de- .
veloped irreversible shock.
(c) Wiggers et aP8 showed that the use of a vasopressor
might transform 'impending' into 'irreversible' shock.
Why then has noradrenaline been used? It is because
we have been led to believe that the irreversible phase of
shock is myocardial in nature; since then, the primary
and potent action of noradrenaline is believed to be on
the contractibility of the myocardium, it is the drug of
choice.24 There are two objections to this, viz.:
1. Adrenaline does not increase the coronary flow and
in moderate doses will decrease the flow.
2. All irreversible shock is not myocardial in nature,
especially haemorrhagic hypotension, which is the variety
under discussion.
How, then, can satisfactory results be obtained if we in-
crease the work load of the heart without increasing (we
may even decrease) the coronary arterial flow? The uni-
formly poor results of noradrenaline in controlled series
do not seem to warrant the routine use of the drug in
haemorrhagic hypotension.
Mural Tension and Blood Pressure
Two other facts warrant consideratio~, one a mechanical
force and the other related to blood-pressure estimations.
Burton25 has shown that with reduction in the diameter
of blood vessels the chances of closure of the lumen secondary
to 'tensions forces' in the walls are greatly increased. This
postulate is in accordance with the Laplace theory of the-
'paradox of the elastic cylinder'. This state of affairs would
not apply if vasoconstriction, i.e. the active 'tensions force',
is prevented.
There are limitations to the accuracy of baumanometer
estimations of blood pressure. Sharpey-Schafer26 has pointed
out that thick arms produce false readings and that this
method breaks down when the mean and pulse pressures
are low or the peripheral vessels are so constricted as to
damp out the small pulsations needed to detect systolic
level. Boba and Converse have noted that the blood pressure
as measured by an intra-arterial cannula is not an index of
capillary circulation. Clinical observation and experimental
evidence tend to prove that tissue flow and arterial pressure
cannot be directly correlated, and in fact may be completely
divorced from each other. Their statement that 'meticulous
and assiduous regular estimation of blood pressure is prob-
ably more for the therapy of the doctor in attendance than
28
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for the patient' highlights this long and deep-rooted fallacy
of the importance of maintaining the blood pressure at all
costs.
Philosophy of Therapy
If one can conceive that an acute, severe haemorrhagic
episode is an experience that the body was not designed to
withstand for any length of time, then one may accept the
principle that our therapeutic efforts need not mimic normal
physiological responses. In a sense, we should not strive
for 'fitness' of the individual in order to observe Cannon's
'fight or flight' theme, but rather for preservation of via-
bility of tissues and organs. Viability does not of necessity
imply function. This point has been carried to an extreme
in hypothermic anaesthesia, where all bodily functions,
including cardiac activity, are suppressed so that the body
can withstand insults which are considerably beyond its
normal limits of tolerance.
The Essential Problem in Treatment
In a final analysis, therefore, the survival of the organism
depends upon the supply of oxygen and nutritive materials
to the tissues. This is facilitated by an adequate blood
flow to the tissues, which is in essence the prime purpose
for which the cardiovascular system was designed. With
loss of blood the peripheral flow in many regions is reduced
below the point where oxidative tissue metabolism can be
effectively carried out. This reduction in flow is due to a
widespread peripheral vasoconstriction compensating for
the inability of the heart to maintain an effective cardiac
output and blood pressure. The net result is a' compensatory
situation in which blood pressure is maintained at the ex-
pense of blood flow to the tissues. In this situation the
relative autonomy of the terminal vascular bed becomes
the dominant factor and gives rise to changes antagonistic
to the initial compensatory readjustment. The longer this
stage of the syndrome is allowed to progress the more re-
fractory to fluid replacement the body becomes, and fatal
circulatory collapse ensues. This imbalance of blood loss
and the vasoconstrictor response is contained in Boba and
Converse's apt definition of shock, viz., 'The sympathetic
response to an acute reduction in cardiac output (primary
or secondary) wherein the response becomes an independent
noxious stimulus'. There are thus two major problems in
therapy, viz.:
1. To combat the decrease in cardiac output.
2. To prevent damage from the prolonged overwhelming
sympathetic vasoconstrictor response.
With h emorrhage the decrease in cardiac output is
secondary to a decrease in venous return, and is treated by
blood replacement.
The rational approach to the treatment of the vaso-
cQnstrictor response is fairly obvious. Firstly, it is important
to interrupt the train of events progressing to irreversibility.
Sec<mdly it is desirable that the barrier against rapid blood
replacement which vasoconstriction causes should be re-
moved. Finally, the blood that is transfused should be able
to reach the tissues. In other words, not only is it important
to restore blood volume, but we must ensure that the blood
is able to subserve its vital function of maintaining cellular
integrity and viability.
Administration of a ganglion-blocking agent, by virtue
of its vasodilator effect, will satisfy the above criteriae.
Ganglioplegic Effects on Special Organs
The use of deliberate hypotension in anaesthesia has
stimulated a number of investigations in the field of circula-
tion at low pressures, which serve to indicate that some of
our commonly accepted concepts need re-evaluation.
In the kidney after injection of a ganglion-blocking agent
very little change in renal blood flow can be observed.
If the blood pressure is then raised with a sympathomimetic
amine a sharp fall in renal blood flow co-existent with an
increase in systolic blood pressure can be demonstrated.n,n
Even at extremely low heads of systemic blood pressure,
urinary output is maintained, though somewhat depressed.28
In the brain the circulation may be 'pressure regulated',
or at least the calibre Qf an artery may Be a pure function
of the head of pressure w which it is exposed.2a,80 With
low arterial pressures (regardless of how achieved) cerebral
vasodilation is the response. With high arterial pressures
vasoconstriction is the response. The vessels of the brain
are apparently designed to regulate the resistance to flow
in their own circulatory area. Ketyet al.31 defined the
term 'cerebrovascular resistance', ai:J.d showed that its value
varies in the same direction as the arterial blood pressure.
This in no way contradicts the fact that anoxia is a powerful
stimulus' to cerebral vasodilation. Philosophically, the
cerebrovascular response to anoxia supports the concept
that vasodilation affords better circulation.
As regards the heart, there are two factors operating
from the administration of a ganglion-blocking agent, viz.
(1) a reduction in the work of the heart as a consequence
of decreased peripheral resistance, and (2) a reduction in
coronary arterial flow. Hackel et al.82 and Eckenhoff et al.,83
working under experimental conditions, have reached the
conclusion that with reduced peripheral resistance the
reduction in cardiac work is relatively greater than the
reduction in coronary flow.
Capillary Reinfusion or Auto-infusion
It is important to reiterate that ganglion-blocking agents
should not be exhibited unless there is adequate blood
available for concomitant transfusion. The quantity of
blood replaced calls for comment, and Ruscoe Clark's34
contention that what is required is 'bigger and better' trans-
fusions needs some modification, based on-the phenomenon
of capillary reinfusion, sometimes labelled auto-infusion.
The reinfusion which occurs immediately after haemor-
rhagic shock has been observed directly by deterrninations
of the total blood volume before and arter haemorrhage,35
and indirectly by observing the cardiovascular response
to the quick reinjection of all shed blood.20 It has a1sD been
shown that rapid transfusion of volumes equal to those
removed from experimentally bled animals has produced
primary cardiac failure because the post-transfusion blood
volume exceeds the volume before haemorrhage.88,37 This
is responsible for the theory of partial replacement· therapy
which is discussed below.
If the source of the additional fluid is the extravascular
space, and if the shift occurs at the capillary bed, certain
corollaries should follow:
(a) The amount of blood that can be shed with one maxi-
mal bleeding must be unpredictable because it is related to
the functional status of the animal, including fluid reserves
and the ability to mobilize these reserves. This has been
demonstrated experimentally.35,38
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(b) U the source of the fluid is the extravascular com-
partment and if this reservoir is not replenished, a succeeding
lethal haemorrhage should not yield as much blood as it
would under normal conditions. Foreman37 has shown
that the bleeding volume of dogs subjected to a shocking
procedure 1 hour before the lethal haemorrhage was con-
sistently lower than the bleeding volume in a series of normal
control dogs.
Because the extravascular fluid spaces must supply a
reservoir of fluid for withdrawal into the intravascular
compartment the use of intravenous glucose in water or
normal saline to replace this reservoir is of some importance.
With intense precapillary vasoconstriction the hydro-
static pressure of the capillary will drop, and a level will
be reached where the osmotic pressure of the plasma is
higher than that of the hydrostatic pressure, and thus the
flow of fluid will be reversed and pass into the intravascular
compartment. It has been stated that. the beneficial effects
of the ganglion-blocking agents are due to the fact, that
.by preventing vasoconstriction, a greater surface for re-
infusion is afforded. ls
CASES TREATED
Six cases, 3 treated with chlorpromazine and 3 with arfonad,
will now be described. This series is very small, which is
due to the fact that only cases that were severely shocked
and might have succumbed to conventional therapy were
treated-in an endeavour to assess the merit of the clinical
applications of this concept and not to be lulled into a
false sense of security and success by treating milder cases
that would ~ave responded to simpler means.
Most of the published work on the use of ganglion-blocking
agents has been done in experimental animals, and very
little in human beings.
Chlorpromazine
Case 1
A 20-year-old Bantu male, admitted comatose, pulseless and
with cold extremities, Cheyne-Stokes breathing, and blood pressure
80/0 mm. Rg. Bright red blood was catheterized and there was
marked bruising over the right loin. A diagnosis of ruptured
kidney was made; in addition displaced fragments of the pelvis
could be felt per rectum.
Blood transfusion was immediately commenced and 12· 5 mg.
of chlorpromazine was given intravenously 35 minutes after
admission. A noticeable effect following the chlorpromazine
was the greater speed with which the blood could be administered.
The extremities became warmer and the blood pressure rose
to 90/25. In 2 hours 6 pints of blood, I pint of dextran, 1 pint of
plasma and 1 litre of dextrose-saline was given. The patient, how-
ever, never recovered consciousness, and he died on the way to
the operating theatre.
-Case 2
An obese 65-year-old Malay female, admitted with a 14-hour
history. She was grey, exhibited marked pallor, and had cold
extremities and a very thready pulse. The abdomen was dis-
tended and rigid, and X-ray revealed the presence of gas under
both sides of the diaphragm. ECG showed evidence of a postero-
lateral cardiac infarct, probably not of recent origin. In spite
of the indications for surgery she was not considered a good
candidate, because the exact diagnosis was in doubt.
Blood and plasma were administered and also 25 mg. of chlor-
promazine intravenously. An apparent improvement was noted
in that the extremities became warmer and pink. Laparotomy
was performed 3 hours later, when a duodenal perforation was
sutured and 5 stones removed from the gall-bladder. The patient
made an uneventful recovery and was discharged 10 days later.
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Case 3
A Bantu male aged 22 years, assaulted. Examination revealed
multiple stab wounds as well as a large left haemothorax with
mediastinal shift. The patient was pulseless and cold and had no
recordable blood pressure. Blood transfusion was commenced
and he responded; but I hour after admission he collapsed, and
the wound in his chest began to expand with blood. Largactil
25 mg. intravenously, was given at this point, and the chest wound
was opened in the ward, clot evacuated, and a bleeding inter-
costal vessel clamped and ligated. He was given further trans-
fusion and made a good recovery.
Chlorpromazine has shown to have beneficial effects as
-a pre-shocking procedure.2l This is borne out by the re-
sponse in case 2 and to some extent in case 3. Case I, being
an already established case of shock did not respond, which
supports the conclusion from the experimental work of
Hershey et 01. 21 that the administration of chlorpromazine
after the onset of haemorrhage does not afford protection.
Furthermore, chlorpromazine has various mechanisms of
action and has the undesirable effect of increasing the pulse
rate.
Arfonad
Arfonad (d-3,4 (l /, 3/-dibenzyl-2/-ketonim-idazolido-l,2-
trimethylene thiophanium d-camphor sulphonate) is a
thiophanium derivative which has the characteristic gang-
lionic blocking and hypotensive effect of tetra-ethyl-
ammonium bromide (TEA),3S and its main action in man
is assumed to be primarily ganglionic blockade. Sarnoff
et al.H state that the continuous graded intravenous ad-
ministration of arfonad appears to 'provide a quantitative
method of diminishing peripheral vascular resistance, in a
gentler and more promptly controllable manner than has
been possible by other means', and they suggested its use
in the treatment of pulmonary oedema. Arfonad has assumed
an increasingly important place in the production of deliber-
ate hypotension during surgery.40-43
Arfonad was first used in the treatment of haemorrhagic
shock by Converse et 0[.29,44 They treated 8 cases witli
'heartening' success in 25 %. In all cases the haemorrhage
occurred in the operating theatre. This had the advantage
that the blood loss could be accurately estimated, and
also that therapy could be undertaken relatively early.
The 3 cases treated in the present series are as follows:
Case 1
A Bantu male aged 56 years, who had undergone 5 operations
for tuberculous peritonitis and adhesions with obstruction. He
was still left with a faecal fistula of the small bowel, and a distal
block in (he caecal area. Laparotomy was undertaken, the fistula
closed, and a right hemicolectomy performed.
He recovered from the anaesthetic and was returned to the
ward. One hour later he suddenly deteriorated. He was now
cold, pulseless and cyanotic, with no recordable blood pressure.
In addition his dressings were soaked with blood and, on re-
moval of these, blood was found to be gushing out of his drainage
tube.
Re was immediately taken to the theatre, where blood trans-
fusion was commenced and arfonad administered at the same time
as a 0·1 % solution in normal saline. The response was satis-
factory in that the patient became warm and pink and the bleeding
did not increase. The abdomen was reopened and unfortunately
no single bleeder was found. Instead a widespread and diffuse
ooze was present, which it was impossible to control, despite
adequate blood replacement. The abdomen was packed, but the
patient died, and the cause of death was thought to be a disorder
of coagulation.
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Case 2
A Bantu female 49 years old, admitted with a history of having
been kicked in the abdomen 20 hours before admission. On
examination the abdomen was found to be rigid. Laparotomy
was performed and gross peritonitis due to a traumatic perforation
of the terminal ileum was dealt with. Just as the peritoneum was
about to be closed cardiac arrest supervened. A left thoracotomy
was immediately performed and cardiac massage instituted.
With the return of the cardiac beat arfonad infusion was com-
menced. The patient recovered and was returned to the ward.
She regained consciousness completely and was perfectly rational
She still showed signs of toxaemia and 28 hours after operation
there was, if anything, some deterioration in her condition. Levo-
phed was then administered. She died 20 minutes later.
Case 3
female Bantu aged 38 years, admitted to the gynaecological
ward. She was suffering from stage-Ill carcinoma of the cervix,
which had been treated with radium 6 weeks before admission.
She was extremely pale, with a very thready pulse, dry tongue
and shrunken eyes, and extremely restless, and there was profuse
bleeding from the vagina. The blood pressure was 50/0 mm. Hg
and the haemoglobin 4·5 gm.%.
She was plugged vaginally and 5 pints of blood immediately
transfused. As her blood pressure began to rise and as the last
pint of blood was running in, another profuse vaginal haemorrhage
occurred, with extrusion of the plug. She was now again very
pale and pulseless, no blood pressure was obtained, and she was
very thirsty and drowsy. Arfonad infusion of 0·1 %. in normal
saline as well as further blood transfusion was commenced. The
patient improved and the arfonad was continued over the next
24 hours, a total of 800 mg. being administered. BLood replace-
ment was continued, a further 4 pints being given.
The patient recovered; she was no longer thirsty or restless
and her blood pressure rose to 90/60, which she tolerated without
any ill effects; the daily output of urine was 700 c.c. The vaginal
pack was subsequently removed with no recurrence of bleeding,
and she was discharged from hospital without any cerebral com-
plications.
In these cases shock had been present for some time and
was very well developed when arfonad was administered.
Although 2 out of the 3 patients finally died, they died of
other factors and not because of the administration of
arfonad.
The survival rate in the 6 cases reported is not statistic-
.ally significant, but it does appear that a ganglion-blocking
agent with the attributes of ready controllability and speed
of action is of considerable value in the treatment of hae-
morrhage.
DISCUSSION
No undue emphasis was placed on blood-pressure estima-
tions, the colour and temperature of the extremities being
used as an index of beneficial response. Nor was any attempt
made to replace the blood loss volume for volume.
Converse .et a/.44 have demonstrated, by estimations of
blood volume made with radiocmomate-51, that induction
of hypotension in animals with arfonad results in an auto-
infusion of 7-12% of the control volume. Thus, if the small
clinical experience here reported, together with the work of
Converse et af. is integrated with the laboratory experience
of others, it would appear that controlled vasodilation
produced by drugs takes advantage of the beneficial fraction
of the normal response to loss of intravascular fluid, while
blocking those responses which in themselves may become
pathophysiological stimuli. In other words, part of the
normal mechanism for defence against blood loss is main-
tained, viz. low capillary pressure allowing reinfusion from
extravascular fluid spaces to take place, while vasocon-
striction with its attendant anoxia is effectively blocked.
The previously mentioned concept of maintaining blood
flow to all organs-temporarily permitting viability but
not function-appears' to be satisfied. It must again be
.stressed that ganglion-blocking agents should on no account
be administered without adequate and similtaneous blood
replacement.
There must be limits' to this method of therapy. It is
obviously of some importance to give quantitative expression
to these limitations ID regard to the parameters of blood
volume in which this approach can function. In age groups
in which atherosclerosis produces a rigid vascular system,
the haemodynamic responses postulated for this mode of
treatment probably do not obtain. It also appears to be
essential to use gravity as an aid to cerebral blood flow in
the presence of very subnormal pressures.
The Physiological Significance of the Autonomic Nervous
System
The study of the above-mentioned pathophysiological
states, if followed to a logical conclusion, leads to the rather
disconcerting conclusion that the autonomic nervous system
may be a liability to the body.2 This trend of thought makes
the concept of ganglion blockade in haemorrhage less
incongruous than it at first might appear.
The usual teaching about the sympatho-adrenal system is
based on Cannon's work45 and is expressed in the classical
statement that it is a system which confers an advantage
on the organism when it meets emergency of some sort,
resulting in the need for staying to fight, or taking flight,
or expressing fright. It is fairly obvious from experimental
and clinical evidence that this system is not essential for
ordinary life. Cannon himself showed that after the sym-
pathetic nervous system had been ablated a cat could still
lead a relatively normal life.
The sympathetic system does not play the vital role in
survival of the organism that the adrenals, pituitary, kidneys
and liver play. It becomes apparent that however important
the autonomic nervous system may have been for some
lower organism, it no longer occupies such a key position
for mammalian life, or in particular for human life. Indeed,
its pr~ence may in fact amount to a liability, in that it makes
possible the play of emotion of all sorts. on our viscera,
and so, perhaps, gi,:es rise to the psychosomatic disorders.
It is interesting, philosophically, to balance the phYSIO-
logical loss which would be incurred by abrogating our
right to an autonomic nervous system against the clinical
gain in the diseases from which we should be freed.
However, Cannon's view was that the sympathetic played
its role not in normal life but under emergency conditions.
If this were true it would be difficult to see how inactivation
of the sympathetic by drugs could favour survival in haemor-
rhage, tourniquest shock, or poisoning with anticholines-
terases. It would also be impossible to accept that the
human organism is made ready for elaborate and taxing
surgical procedures when all the autonomic defences are
shattered by refrigeration and whole batteries of paralytic
cocktails.
The impression is thus gained that the autonomic nervous
system is an evolutionary heritage which, however useful
in 'Our ancestral past, now seems to be out of gear with the
requirements of human life, with its continued and varied
emotional pressures.
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SUMMARY
1. Evidence is submitted of the lethal part that vaso-
constriction can play in the development of 'irreversibility'.
2. The deleterious effect, and the irrational basis for the
use, of vasopressor therapy is detailed.
3. The beneficial effects of counteracting the vasocon-
strictor response by destroying nervous pathways and by
means of ganglion-blocking agents is demonstrated.
4. The fallacy of a direct relationship between blood
pressure and tissue flow is indicated.
5. The concept of concenhating on viability rather than
on function as an initial measure by using ganglion-blocking
agents (in addition to blood transfusion) is elaborated.
6. Certain characteristics and effects of these agents are
noted.
7. A small series of 6 ·cases treated is presented.
8. The philosophy that the autonomic nervous system
has outgrown its usefulness to man and represents an evolu-
tionary heritage is suggested.
I should like to thank Dr. M. Barlow and Dr. J. Gottlich fortheir
help in treating some of the cases. I am indebted to Prof. D. J. du
Plessis and Mr. Boris Lewin for reading the manuscript. To
Dr. G. D. ElJiott, Superintendent of Coronation Hospital, I am
grateful for permission to report on the cases treated.
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CHLORPROPAMIDE* (DIABINESE) IN DIABETES, WITH SPECIAL REFERENCE
TO TOLBUTAMIDE-FAILED CASES .
JOSEPH B. HERMAN, B.Sc., M.B., CH.B., and W. P. U. JACKSON, M.D., M.R.C.P.
Diabetic Clinic, Department of Medicine, Groote Schuur Hospital and University of Cape Town
In this age of great therapeutic advances we are witnessing the
apparent paradox ofpharmacological substances-the sulpho-
nylurea drugs-being used for the correction of a physio-
logical aberration such as diabetes on the one hand, and on the
other hand of a physiological agent~ortisone-being used
for the treatment or 'cure' of a variety of inflammatory and
allergic conditions.
With the discovery of insulin it seemed that the final answer
to diabetic treatment was at hand, but as time has gone on it
has become clear that insulin is necessary only in a proportion
of diabetics. In the acute-onset diabetes of the juvenile type,
often associated with ketosis, insulin will largely correct the
physiological abnormality. The maturity-onset type of dia-
betic-who has been shown to have available insulin in his
plasma-is not fundamentally benefited, as far as we know,
by exogenous insulin.
Attempts to correct the hyperglycaemia in diabetes by
drugs other than insulin proved unsuccessful or impracticable
• Produced by the Pfizer Laboratories, of America, under the
trade name Diabinese. We are indebted to Messrs. Pfizer, of
Johannesburg, for initial supplies of this drug.
until the advent of the sulphonylureas. It is problematical
whether the other biochemical abnormalities of diabetes
mellitus are corrected by these pharmacological agents.
In the treatment of diabetes mellitus our aim should be the
search for the biochemical abnormality and its correction.
The sulphonylurea drugs may prove to be a stepping stone in
this direction.
The sintilarity of the chemical structure of the sulphonyl-
ureas is evident from their formulae:
H:aN C> S02NH ' CO· NH· C4H 9
Carbutamide (BZ 55)
CH3 C> S02NH ' CO· NH· C4H 9
Tolbutamide (D 860)
a <=> S02NH' CO· NH· CaH7
CWorpropamide
Carbutamide (BZ55) is generally believed to be too toxic
for routine use. With the replacement of the NHz group by
CH3 (tolbutamide) the toxic effects were greatly diminished,
